Article History
First Online: 9 April 2019
Competing interests
: D.E.F. has a financial interest associated with Soltego, which was reviewed and is currently managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. K.T.F. serves on the Board of Directors of Clovis Oncology, Loxo Oncology, Strata Oncology and Vivid Biosciences; serves on the Corporate Advisory Boards of PIC Therapeutics and X4 Pharmaceuticals; serves on the Scientific Advisory Boards of Adaptimmune, Aeglea, Amgen, Apricity, Arch Oncology, Array BioPharma, Asana, Fog Pharma, Fount, Neon Therapeutics, Oncoceutics, Sanofi, Shattuck Labs, Tolero and Tvardi; and is a consultant to Bristol-Myers Squibb, Boston Biomedical, Cell Medica, Checkmate, Debiopharm, Genentech, Merck, Novartis, Pierre Fabre, Takeda and Verastem. X.B. declares no competing interests.